NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · Seattle Cancer Care Alliance · +45 more institutions
Abstract
The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.
Citation impact
- FWCI
- 26.16
- Percentile
- 100%
- References
- 73
Authors
32- JAJohn A. ThompsonCorresponding
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Seattle Cancer Care Alliance, Fred Hutch Cancer Center, Cancer Research Center
- BJBryan J. Schneider
University of Michigan
- JRJulie R. Brahmer
Sidney Kimmel Comprehensive Cancer Center
- SAStephanie Andrews
Moffitt Cancer Center
- PAPhilippe Armand
Dana-Farber Brigham Cancer Center
Topics & keywords
- Medicine
- Immunotherapy
- Adverse effect
- Intensive care medicine
- Diarrhea
- Cancer immunotherapy
- Cancer
- Oncology
- Good health and well-being